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Abstract
Bovine seminal (BS) RNase, the unique natively dimeric member of the RNase super-family, represents a special case not
only for its additional biological actions but also for the singular features of 3D domain swapping. The native enzyme is
indeed a mixture of two isoforms: M = M, a dimer held together by two inter-subunit disulfide bonds, and MxM, 70% of
the total, which, besides the two mentioned disulfides, is additionally stabilized by the swapping of its N-termini. When
lyophilized from 40% acetic acid, BS-RNase oligomerizes as the super-family proto-type RNase A does. In this paper, we
induced BS-RNase self-association and analyzed the multimers by size-exclusion chromatography, cross-linking,
electrophoresis, mutagenesis, dynamic light scattering, molecular modelling. Finally, we evaluated their enzymatic and
cytotoxic activities. Several BS-RNase domain-swapped oligomers were detected, including two tetramers, one exchanging
only the N-termini, the other being either N- or C-swapped. The C-swapping event, confirmed by results on a BS-K113N
mutant, has been firstly seen in BS-RNase here, and probably stabilizes also multimers larger than tetramers. Interestingly,
all BS-RNase oligomers are more enzymatically active than the native dimer and, above all, they display a cytotoxic activity
that definitely increases with the molecular weight of the multimers. This latter feature, to date unknown for BS-RNase,
suggests again that the self-association of RNases strongly modulates their biological and potentially therapeutic properties.
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Introduction
Bovine seminal ribonuclease (BS-RNase) is the sole natively
dimeric [1] member of the pancreatic-type RNase super-family
[2], and it is a mixture of two isoforms. The first, called M=M,
accounts for about the 30% of the total, and it is dimeric due to
two anti-parallel disulfide bonds linking the Cys-31 and 32 of the
two subunits [3,4]; the second isoform, called MxM, (70% of the
total) is stabilized, in addition to the mentioned disulfides, also by
the three dimensional (3D) swapping [5] of its N-terminal domains
(residues 1–15) [6]. BS-RNase is endowed with special biological
actions, especially a potentially therapeutic antitumor activity [7].
Notably, only MxM is selectively [8] cytotoxic against malignant
cells [9], because it maintains the dimeric structure necessary to
evade the RNase inhibitor (RI) even under the reducing cytosolic
environment that breaks the inter-subunits disulfide bonds and
causes the disassociation of the unswapped M=M form [9,10].
Libonati first showed that, when dissolved in 40–50% acetic
acid (HAc) and subjected to lyophilization [11], BS-RNase forms a
mixture of meta-stable oligomeric aggregates [12], whose stability
increases in sodium phosphate buffers (NaPi), as occurs to bovine
pancreatic ribonuclease (RNase A), the monomeric proto-type of
the super-family [11]. Later, Mazzarella and colleagues hypoth-
esized the existence of more than one tetrameric isoform
(dimer+dimer) ascribable to different induced orientations of the
BS-RNase N-termini [13]. Nevertheless, despite many studies
focused on the propensity to natively swap its N-termini [14–18]
no additional investigations on BS-RNase oligomers have been
performed. However, the high sequence identity (about 82%)
existing between BS-RNase and RNase A [4], and the similar
chromatographic behavior of the two proteins after their multi-
merization [12,13], has lead us to hypothesize that BS-RNase
could oligomerize through the same mechanism of its pancreatic
monomeric counterpart, i.e. the double domain swapping [19] of
both N- and/or C-termini [20,21].
It is noteworthy that the 3D domain swapping mechanism is
shared by several fibril-forming proteins, such as cystatin C
[22,23], human prion protein [24,25], T7-Endonuclase I [26], b-2
microglobulin [27,28], but also by proteins that are not
fibrillogenic, such as cytochrome c [29], and RNase A [20]. By
the way, RNase A is considered a model for the formation of
amyloid or amyloid-like fibrils through domain swapping [19],
although only mutants containing poly-Q- or poly-G-expanded
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loops were shown to produce native-like fibrils [30,31]. Contrarily,
no conditions yielded fibrils from wt RNase A [31,32], even if this
enzyme displays more than one cross-b-spine-prone sequence
[33], and although more recently another pancreatic-type [2]
RNase, the eosinophil cationic protein (ECP), was shown to form
fibrils [34]. Anyway, RNase A can form several N-or C-domain-
swapped oligomers [20,21] if it is lyophilized from 40% HAc
solutions [11], or if highly concentrated protein solutions are
subjected to a thermally-induced aggregation procedure [35]. In
addition, it has recently been discovered that minor but not
negligible amounts of dimers, especially the C-swapped one, are
produced in vitro in CHO cells and in vivo in bovine pancreatic
tissue [36]. The structures of RNase A N-swapped or C-swapped
dimers, or of a C-swapped cyclic trimer, called ND, CD and CT
respectively [20], have been solved (PDB codes 1A2W, 1F0V,
1JS0, respectively) [37–39], while plausible models have been
proposed for RNase A tetramers and larger oligomers [21,40,41].
Although being meta-stable, all multimers maintain and/or
increase their enzymatic and biological activities, becoming also
cytotoxic in vitro and in vivo [42], depending on their mass (i.e.
degree of oligomerization), and on the number and/or exposure of
basic charges, these latter features differently related to N- or C-
swapped structures [20].
In this composite scenario, the characterization of BS-RNase
oligomerization profile could further elucidate the structural
determinants controlling the self-association of RNase(s) and of
proteins in general [43]. In addition, considering the cytotoxic
potential of the seminal enzyme [8], it would be very interesting to
see if also BS-RNase multimers display augmented catalytic and/
or, above all, biological activities. Thus, we induced BS-RNase
multimerization through the mentioned protocols [11,35], and the
oligomers produced were purified and studied in their structural
and functional properties, side-by-side with the well characterized
RNase A oligomers [20,21,37–40], employed in this study as
standards.
Results and Discussion
BS-RNase aggregation, purification, and analysis of the
oligomeric products
To avoid spontaneous deamidation, heterogeneity of the
samples and side-reactions, the protein used here as wt is N67D-
BS-RNase [44] (See Materials and Methods), considering that the
biological and structural features of this protein are known to be
almost identical to those of the native enzyme [45].
BS-RNase multimers were firstly obtained upon subjecting the
protein to incubation in 40% HAc followed by lyophilization
[11,12]. These conditions are known to extensively denature
RNase A [46], with its oligomers forming only when the
lyophilized powder is re-dissolved in ‘‘benign buffers’’ [46], like
NaPi. Accordingly, one would expect similar results with BS-
RNase when incubating either a pure isoform or any combination
of them; therefore, for sake of clarity, all BS-RNase oligomers have
been produced starting from the equilibrium mixture of the two
native isoforms [6], i.e. M=M and MxM.
Preliminary results obtained through size-exclusion chromatog-
raphy (SEC) with a Sephadex G-100 column showed the presence
of BS-RNase tetramers (TT), hexamers (H), and larger oligomers
(L.O.) (Figure 1A). The chromatographic medium is crucial to
purify different RNase oligomeric isoforms, but no improvement
was achieved with a Superdex 200 column (data not shown). In
contrast, a superior separation was obtained using a Superdex 75
10/300 GL column (Figure 1B, continuous line), reporting the
yields of all BS-RNase oligomers in Table 1. We also attempted to
refine the separation using two different cation-exchange columns,
but, contrarily to RNase A [20], no conditions allowed us to
improve the quality of the purification previously obtained with
SEC (data not shown).
The BS-RNase pattern of Figure 1B is superimposed with the
known [20] RNase A oligomerization profile (dashed line). By the
way, we recall here that BS-RNase is a covalent dimer [3], while
RNase A is natively monomeric. Therefore, the multimerization
sequence of the seminal variant is dimer.tetramer(s).hexamer(-
s).octamer(s), etc, and accounts for the absence of BS-RNase
peaks co-eluting with monomeric, trimeric and pentameric (data
not shown, and [21]) RNase A. Nevertheless, the two RNases’
profiles showed strong similarities: in fact, BS-RNase (native)
dimer (fractions 7, 8, Figure 1B) eluted at the same volume of
RNase A-CD [20,38]; in addition, a composite peak (fraction 5, 6)
co-eluted with RNase A tetramers (NCNTT and CNCTT [20], in
the grey magnification) and a composite peak (fractions 3, 4)
overlaps the RNase A hexameric traces, whose position was
determined in previous studies [21]; finally, also traces of larger
BS-RNase multimers (octamers and so on) were clearly visible
(fractions 1, 2). Each numbered fraction was separated, concen-
trated, and analyzed through 10% cathodic PAGE under non-
denaturing conditions [47] (Figure S1), confirming that all peaks
are BS-tetramers (TT, fractions 5, 6), hexamers (H, fractions 3, 4)
and larger oligomers (L.O., fractions 1, 2), respectively, as reported
in Figure 1C. Moreover, in panel C, at least two BS-hexamers (H1
and H2), and especially two different tetramers (TT1 and TT2) are
visible. A 7.5% non-denaturing cathodic PAGE of tetramers (inset
of Figure 1C) deriving from three preparations showed that BS-
TT1 and -TT2 display different electrophoretic mobilities and
shapes, with alterations in the charged groups exposure, or both
[40]. Anyhow, although TT1 and TT2 are qualitatively different,
they were not completely purified from each other. Thus, we
collected their mixture, concentrated it in 0.4 M NaPi to the
smallest volume possible, and re-chromatographed in the Super-
dex 75 column equilibrated with the same buffer (Figure 1D,
dashed+dotted line). The two fractions collected were further
purified and the separation was definitely satisfactory for TT1
(continuous line). Contrarily, it was not possible to completely
purify TT2, even after two consecutive attempts (dotted and
dashed lines, respectively). Nevertheless, the residual contaminant
TT1 was only about 15% (dashed line), and the first part of TT2
peak was discarded for further analyses. Thus, also after this last
purification the two tetramers confirmed to have different shape,
and this fact is somehow surprising, considering the similar size,
shape and charge exposure of the two BS-N-swapped tetrameric
models proposed by Mazzarella and colleagues [13] and shown in
the right part of Figure 1D: these two structures differ, in fact, only
in the orientation of the N-swapped domains, and they are
chromatographically undistinguishable. They represent the only
possibility for BS-RNase to form different N-swapped tetramers,
taking also into account the constraint given by the two disulfides
involving Cys-31 and -32 that link the two subunits of the native
dimer. Thus, a domain other than the N-terminus has to swap to
justify the different behavior of BS-TT1 and -TT2, and the C-
terminus can be the logical candidate to be swapped. This
hypothesis is enforced by the evidence that, in SEC, RNase A-CD
partially precedes the N-dimer (ND, Figure 1B, dashed line), as BS-
TT1 does towards BS-TT2. Consequently, BS-TT1 should be the
C-swapped conformer, while BS-TT2 is assignable to one, or both,
of the two N-swapped models proposed by Mazzarella and co-
workers [13].
Biologically Active N/C-Swapped BS-RNase Multimers
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Cross-linking of BS-RNase with DVS and DFDNB
Divinylsulfone (DVS) cross-links BS-RNase His-12 and His-119
[48], the catalytic residues which lye close to each other at the
active site. Being H12 and 119 at the N- and C-termini of the
enzyme, respectively, DVS will yield oligomers that are stable
under denaturing conditions only if 3D domain swapping had
occurred [48]. Thus, BS-RNase tetramers were distinctly cross-
linked with DVS, and the SDS-PAGE analysis of the reaction
time-course is shown in Figure 2A,B. The reaction yield is low for
both isomers, especially BS-TT1, because the conditions required
for the reaction (sodium acetate, pH 5.0) were not optimal for
oligomers’ stability. Nevertheless, a light band corresponding to a
MW comprised between 45 and 66 kDa, which includes a RNase
tetramer (<55 kDa), was visible for both isomers, indicating their
domain-swapped nature. Furthermore, no higher M.W. bands are
present in the panels, confirming that the two species analyzed are
tetramers, and that no spuriously cross-linking due to occasional
protein collisions occurred.
1,5-difluoro-2,4-dinitrobenzene (DFDNB) permits one to dis-
tinguish between N-terminal and C-terminal swapping because it
selectively cross-links RNase Lys-7 and Lys-41 [49], thus
stabilizing only the N-swapped oligomers. The cross-linking
reaction was performed on both BS-RNase tetramers purified
from SEC, and also on the positive and negative controls, RNase
A-ND and -CD, respectively. The reaction mixtures were analyzed
by SDS-PAGE under reducing and non-reducing conditions
Figure 1. SEC chromatograms and PAGE under non denaturing conditions of BS-RNase aggregates obtained by lyophilising the
protein from a 40% (v/v) acetic acid solution. (A) SEC pattern obtained with a Sephadex G100 column. Elution with ammonium acetate 0.1 M,
pH 5.65, flow rate of 0.4 ml/min. (B) SEC chromatogram of BS-RNase multimers superimposed with that of RNase A oligomers: both patterns were
obtained with a Superdex 75 10/300 GL column. Elution with 0.2 M NaPi, pH 6.7, flow rate 0.1 ml/min. (C) Enlarged Superdex 75 SEC pattern of BS-
RNase aggregates; in the inset, 7.5% non denaturing PAGE of the two BS-tetramers, run-time 110 min. (D) Additional purification of the two BS-RNase
tetramers: their mixture was concentrated to 25 ml in 0.4 M NaPi, and re-chromatographed in the Superdex 75 column equilibrated with the same
buffer (dashed+dotted line). Then, TT1 and TT2 fractions were further purified: once for TT1, continuous line; twice for TT2, dotted and dashed lines,
respectively. In the right part of the panel are reported the models of two N-swapped BS-RNase tetramers proposed by Adinolfi et al. [13]: they
cannot be associated to both tetramers. The various BS-RNase species are: D, native dimer; TT1 and TT2, two tetrameric conformers, H (1 and 2),
hexamers; L.O., larger oligomers. Concerning RNase A, grey italics labels: M, native monomer, ND, N-terminal-swapped dimer, CD, C-terminal-swapped
dimer; T, trimers; NCNTT: double N+C-swapped tetramer; CNCTT: double C+N-swapped tetramer; P*: pentamers; H*: hexamers. The asterisk* is present
to mention that P and H positions are derived from data obtained in [21].
doi:10.1371/journal.pone.0046804.g001
Biologically Active N/C-Swapped BS-RNase Multimers
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(Figure 2C,D): a band of BS-TT2 corresponding to a cross-linked
tetramer indicated by the dotted circle in both panels appears to
be more intense than that of BS-TT1, either under reducing (panel
C) or non-reducing (panel D) conditions. Whereas the results were
not clear-cut, we can envisage that BS-TT1 contains fewer
swapped N-termini than BS-TT2, because it has also to be
considered that a significant tetrameric fraction dissociates before
cross-linking occurs, and the cross-linking yield did not reach
100% even for the positive control, RNase A-ND. Thus, the
DFDNB cross-linking appears helpful enough to support the
hypothesis that BS-TT1 contains the C-terminal swapping, while
BS-TT2 does not. We also cross-linked the native dimer to verify if
the N-terminus lock could decrease or even delete the amount of
N-swapping to occur. After SEC and cation-exchange purification
[50] (Figure S2A,B and Discussion S1 file) the cross-linked protein
was induced to oligomerize [11]. The resulting sample showed,
after SEC purification (Figure S2C, continuous line), only one
tetrameric peak, very probably the C-swapped one. Anyhow, the
wideness and position of the peak (Figure S2C, and Discussion S1
file), cannot allow us to certainly assign it to the C-swapped
isoform.
Table 1. Quantification and structural features of BS-RNase oligomers.
Elution Volume (ml) Yield (% of the total)
Hydrodynamic diameter
(nm)a
BS-RNase species WT K113N WT K113N WT
D 12.2760.18 12.3160.05 58.965.3 53.765.1 7.5360.23
TT2/N
b 11.1960.04 11.3160.09 10.262.2 12.261.0 8.5160.32
TT1/C
b 10.8660.03 11.0860.05 15.862.5 13.361.1 9.6560.29
H 10.3560.09 10.4060.02 9.762.6 10.961.9 ---
L.O.c 9.9260.11 9.8760.04 5.462.5 9.963.4 ---
aCalculated from DLS analysis.
bThe elution volumes of the BS-tetramers derive from their additional SEC purification with 0.4 M NaPi as eluent (see Figure 1D).
cL.O.: mixture of BS-RNase octamers and larger oligomers.
doi:10.1371/journal.pone.0046804.t001
Figure 2. 10% SDS-PAGE analysis of the crosslinking reactions of BS-RNase tetramers. (A), (B) DVS reaction time-course of TT1 and TT2,
respectively. 8 mg of each aliquot-sample was electrophoresed after blocking the reaction with 0.2 M b-mercaptoethanol, final concentration. (C), (D)
DFDNB reaction of BS-RNase tetramers and RNase A dimers analyzed under reducing and non-reducing conditions, respectively. Samples were
concentrated to 1 mg/ml, and 10 mg of each were analyzed.
doi:10.1371/journal.pone.0046804.g002
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Stability of the BS-RNase tetramers
Considering that meta-stability hinders the characterization of
BS-RNase tetramers, we studied their relative dissociation kinetics.
Three SEC chromatograms obtained immediately after dissolving
the lyophilized mixture in 0.2 M NaPi, pH 6.7 (blue curve), or
storing at 4uC two aliquots of it for one or two weeks are shown in
Figure 3A, green and red curves, respectively. The relative
oligomers amounts changed, with BS-TT1 being less stable than
BS-TT2, and this trend was confirmed by the chromatograms of
the two tetramers, analyzed after keeping them isolated from the
other oligomers, and incubated together at 4uC up to three days
(Figure 3B).
In contrast to the extensively studied propensity of BS-RNase to
swap its N-terminus [14–18], either the BS-C-terminus or the
hinge loop linking it to the protein core had never been nowadays
analyzed in detail. Several substitutions are present, in this region,
with respect to RNase A [4]: in particular, G111, K113, and S115
of BS-RNase are, respectively, Glu, Asn and Tyr in RNase A [4].
In particular, the mutation at 113 can be crucial, because Asn-113
stabilizes the open-interface [51] of RNase A-CD, through the
formation of a ‘‘steric zipper poly-Q-like’’ hydrogen bond network
(Figure 3C, left and central panels) [38]. Consequently, the
N113K substitution could destabilize the BS-RNase C-swapped
oligomers (i.e. TT1), by deleting the intermolecular H-bond
between the side chais of the two N113 [38], and possibly
introducing electrostatic repulsion caused by the two complemen-
tary lysines side chains (Figure 3C, right panels). Anyhow, it has to
be considered that the factors governing the interplay of four
subunits are larger than those affecting the interactions of two
protein bodies forming a dimer [50].
Production and self-association of BSK113N (K113N-BS-
RNase)
To evaluate the role of the 113 residue, a BSK113N variant was
produced, purified, and induced to oligomerize by the two
methods [11,35] used for the wt enzyme. The BSK113N
oligomerization induced by 40% HAc/lyophilization produced
the results shown, and compared to those relative to wt, in
Figure 3. Analysis of the stability of BS-RNase oligomers. (A) SEC of the oligomers’ mixture immediately dissolved in 0.2 M NaPi, pH 6.7 (day
0-blue curve), or after storing it at 4uC for one or two weeks (7 and 14 days, green and red curves), keeping constant the amount of the native dimer.
(B) SEC of TT1 and TT2 gathered together immediately after their elution from the oligomers’ mixture (day 0-blue curve, cfr. panel A) and re-
cromatographed after a storage at 4uC in 0.2 M NaPi, pH 6.7, for one, two, or three days (1-red, 2-dark green, 3- pink curves, respectively). The SEC
experiments were carried out with a Superdex 75 column. (C) Left panel, RNase A C-dimer [38], and (central panel) the open interface [51] stabilizing a
C-swapped RNase A oligomer. Right panels, BS-RNase C-swapped open-interface: upper panel, wt (K113); lower panel, BSK113N (N113 interplay, as in
RNase A).
doi:10.1371/journal.pone.0046804.g003
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Figure 4A and Table 1: it is clearly visible the higher aggregation
yield of the mutant (53.7% of residual dimer), in particular of its
larger oligomers (L.O.), with respect to the wt one (58.9% of
dimer), as well as to that of RNase A, whose native residual
monomer recovered after oligomerization is known to reach even
73% [52]. The two BSK113N tetramers were withdrawn, concen-
trated and re-analyzed by SEC (Figure 4B), as was performed with
wt tetramers (see Figure 3B), after one, two or three days. The
results of Figure 4B reveal that, under these environmental
conditions [52–55] BSK113N-TT1 is more resistant to dissociation
than wt BS-TT1, indicating that the stability of this tetramer is
increased by the K113N mutation. Finally, the two BSK113N
tetramers were cross-linked with DFDNB, under the same
conditions used for the wt ones. The SDS-PAGE analysis (Figure
S3) did not show significant differences from the results obtained
with wt tetramers (see Figure 2C,D), indicating that the conditions
required for the DFDNB reaction [49,50] flatten the differences of
stability related to the K113N mutation.
Thermally-induced oligomerization of wt and BSK113N
The ‘thermal aggregation’ approach [35] can provide additional
insights into the BS-RNase self-association mechanism, in
particular into the possible swapping of its C-terminus. This
possibility derives from the matter of fact that RNase A changes its
propensity to swap its N- or C-terminus, or both, depending on the
environmental conditions applied [35]. In particular, mildly
denaturing conditions favor the exchange of RNase A N-terminus
and, consequently, ND formation, while more drastic conditions
induce also the swapping of its C-terminus and formation of CD
[35].
The results of the experiments performed with BS-RNase are
shown in Figure 5. Under all conditions applied for one hour, the
only species of wt BS-RNase visible, besides the native dimer D, is
TT2 (Figure 5A–C, blue curves). The only exception occurred
when 40% aqueous EtOH contained 0.5 M guanidine (final
concentration): in fact, after one hour incubation at 60uC, a little
shoulder, assignable to BS-TT1, is also visible (Figure 5D, blue
curve), although about half of the sample precipitated. On the
contrary, RNase A showed to form, as expected [35], a CD
amount larger than ND when it was incubated under the more
drastic conditions (dotted black curves in A–D panels). Thus,
again, the stability of BS-TT1 is definitely low, and here is
additionally compromised by high temperature: consequently, we
can consider the yields of BS-RNase tetramers as a balance
between conditions severe enough to detach the protein terminals
from the core and mild enough to avoid the dissociation of the
newly formed oligomers [35,53].
The results obtained, in parallel, with BSK113N (red curves) show
that its TT1 is definitely present in every aggregation profile,
although its yield never surpassed that of TT2 (Figure 5B,D). Thus,
the K113N mutation definitely favors BS-TT1 formation and
indirectly confirms that this tetrameric conformer is formed
through the C-terminus swapping. Consequently, the two BS-
RNase tetramers will be called, from now on, TTC and TTN,
respectively, or also TT1/C and TT2/N, as in Figure 5.
In addition, small but detectable amounts of BSK113N oligomers
larger than tetramers (L.O.) are visible in all chromatograms of
Figure 5, especially in panel B (red curve). This result suggests that
also BS large oligomers (L.O.), or some of them, contain C-
swapped termini and that their formation was favored by the
increase of the amount of TT1/C [35].
Finally, the higher the denaturing strength of the medium (i.e.,
containing guanidine), the lower the temperature necessary to
avoid a partial protein precipitation. In fact, substantially equal
amounts of BSK113N-TT1/C and -TT2/C formed (Figure 5C, red
curve) when the temperature decreased from 60 to 45uC, while,
instead, this ‘cooling’ event favored RNase A-ND over -CD (dotted
black curve). Taken together, all these final observations suggest
that the optimal conditions to induce BS-RNase thermal
aggregation are slightly milder than those promoting the same
event in RNase A [35,53].
Dynamic Light Scattering (DLS) and Molecular Modeling
of BS-TT1/C
DLS, which measures the hydrodynamic diameter of a protein
[56], can be useful to obtain informations about the disposition of
the BS-tetramers’ subunits, in particular the differences given by
N- and/or C-swapping. The data obtained (Table 1) show that the
Figure 4. SEC chromatograms of K113N BS-RNase aggregates obtained by lyophilising the protein from a 40% (v/v) acetic acid
solution. (A), Superdex 75 chromatogram of the mutant (blue) overlapped with a chromatogram of wt BS-RNase (red). (B), SEC of K113N BS-TT1 and
TT2 gathered together immediately after their elution from the aggregates mixture (day 0-blue curve) and re-cromatographed after storage in 0.2 M
NaPi, pH 6.7, for one, two, or three days (1-red, 2-dark green, 3-pink curves, respectively).
doi:10.1371/journal.pone.0046804.g004
Biologically Active N/C-Swapped BS-RNase Multimers
PLOS ONE | www.plosone.org 6 October 2012 | Volume 7 | Issue 10 | e46804
hydrodynamic diameter of BS-RNase native dimer is in agreement
with the value relative to its crystallographic structure(s) [57,58].
Instead, the BS-TT2/N diameter is slightly larger and consistent
with the two cyclic N-swapped-only models proposed by Adinolfi
et al. [13]. Finally, as expected from SEC (see Figure 1C), the
diameter measured for BS-TT1/C is larger than the BS-TT2/N
one, and cannot fit the cited models.
Thus, on the basis of DLS data, the known structure of MxM
BS-dimer [57], and the structural constraints imposed by the inter-
subunit disulfides, we modelled the structure of BS-TT1/C. Models
were built by molecular docking, starting from two identical
dimers of wt N-swapped BS-RNase (MxM). Each dimer had one
C-terminus ‘‘opened’’, with a conformation based on the crystal
structure of the C-swapped RNase A (PDB code 1F0V) [38].
Then, fifty putative tetramers were generated and, by the docking
and energy minimization algorithms, three representative low
energy structures were selected and here shown in Figures 6 and
S4. The structure which best fits TT1/C hydrodynamic diameter
(Table 1) is the ‘‘quasi-linear’’ [40] one, visible in two different
orientations in the right and left panels of Figure 6A. This model
can also explain the chromatographic differences existing between
BS-TT1 and -TT2 (see Figure 1, Table 1), and consists of two
native N-swapped dimers (MxM) linked by the swapping of the C-
termini of their central subunits (dimer-C-swap-C-dimer). Thus,
this tetramer globally swaps four N-termini and two central C-
termini, and can be named also BS-NCNTT [20]. Its C-swapped
open interface [51] is stabilized by two inter-subunit H-bonds
forming between the two Gly-112, and between Asp-67 and Val-
116 of the two central complementary subunits (left panel of
Figure 6A). This structure is different from the one of RNase A
NCNTT [40,41] reported in Figure 6B for comparison, although
the swapping sequences of the two tetramers are identical: in fact,
the structural differences existing between of RNase A-ND [37]
and BS-RNase [57] induce different structures in the tetramers. In
Figure S4A,B two alternative BS-NCNTT models, increasingly
bent with respect to the structure of Figure 6A, are shown. These
Figure 5. SEC profiles of wt and K113N BS-RNase aggregates obtained through thermal treatment. The various environmental
conditions applied in aqueous solvents [35] are indicated in each of the A–D panels, in which the profiles obtained with the two BS-RNase variants
(blue and red curves) are compared with the corresponding RNase A chromatograms (dotted black curves). Oligomers were obtained as follows:
tubes containing 2.5–3.0 ml (0.5 mg) of each solution were put for 60 min in a thermostatically controlled bath at one of the temperatures indicated
[35]. Then, 200 ml of 0.2 M NaPi, pH 6.7, heated to the same temperature of incubations [35], were added. Each sample was transferred to an ice-cold
bath for 5 min, then injected onto a gel filtration Superdex 75 HR10/30 column. The different oligomers formed are labeled and correspond to the
ones prepared by the lyophilization procedure (see Figure 1) [11]. GDMCl, guanidine hydrochloride; EtOH, ethanol.
doi:10.1371/journal.pone.0046804.g005
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structures lack the Gly-112 and Asp-67/Val-116 H-bonds of the
‘‘quasi-linear’’ model, and their hydrodynamic diameters are
slightly different from the one measured for TT1/C with DLS
(Table 1), although they represent two other energy minima.
Biological activities of BS-RNase oligomers
Enzymatic assays. Native BS-RNase is known to cleave
double-stranded RNA (dsRNA), as well as the pool of its multimers
does [12], although the activity of the latter has not been studied in
detail yet. Instead, it is well-known that RNase A oligomers
acquire the ability to degrade double-stranded polyribonucleo-
tides, with the C-swapped species being more active than the
corresponding N-swapped conformers [20].
Thus, we tested dimers and oligomers of both wt and BSK113N
on yeast RNA and poly(A)Npoly (U), i.e. single-stranded (ss) and
dsRNA, respectively (Table 2). The data obtained on yeast RNA
confirmed that dimers and multimers of both BS-RNase variants
are active, but somewhat less than monomeric RNase A [12,20]
used here as standard. On the contrary, the multimers of both BS-
variants were more active against poly(A)Npoly(U), with respect to
their corresponding native dimer. Interestingly, the specific activity
definitely increased from BS-dimer to tetramers, but only a slight
activity augment was observed for the oligomers larger than
tetramers (L.O.). Anyway, either wt or BSK113N TT1/Cs were
slightly more active than the corresponding TT2/Ns. This behavior
qualitatively parallels the one of RNase A oligomers ([20] and
Table 2), and can be ascribed to a higher basic charge density or
exposure [2] depending on C-swapping event(s) rather than on N-
swapping(s) [20].
Finally, the BS-dimer of wt was slightly more active than the
K113N one (Table 2). Contrarily, the activities displayed by the
homologous wt or BSK113N multimers were almost comprised
within the experimental error, indicating that the loss of K113
positive charge did not significantly affect the catalytic activity of
BS-RNase oligomers. Considering that dsRNAase activity increas-
es with the positive charge density of the active site region [2,20],
we can envisage that the charge of K113 side chain does not affect
RNase-dsRNA recognition.
Cytotoxicity assays. It was mentioned before that native BS-
RNase displays several biological actions, especially a potentially
therapeutic cytotoxic activity [7,8], owned by only the N-swapped
(MxM) dimeric isoform [9,10]. Thus, on the basis of the enzymatic
activities reported (Table 2), we evaluated if BS-RNase multi-
merization could affect the cytotoxic potential of the native dimer.
To avoid to collect data derived by genetic alterations of
immortalized or tumor cell lines, the primary mesenchymal cell
line VIT1 was chosen here as a model to analyze the inhibitory
effect of both BS-RNase variants on cell growth. Cells were treated
with increasing concentrations of dimer (D), or of TT1/C, TT2/N,
or a mixture of BS-L.O.. In Figure 7, it is clearly visible that both
wt and BSK113N multimers display a cytotoxic activity higher than
the corresponding dimers, in parallel with the enzymatic activity
trend [20,42], and in line with previous data obtained with RNase
A oligomers [42]. In particular, Table 2 reports that wt and
BSK113N tetramers’ IC50 values, obtained from growth inhibition
curves shown in Figure 7, are about 10-fold, and more than 3.7-
fold, lower than those of their native dimers, respectively. In
addition, our data show that, within the same BS-RNase species,
the two tetramers display an activity very similar to each other,
and that BS-RNase larger oligomers (L.O.) decrease the IC50
value 17-fold for wt, and more than 6.3-fold for BSK113N, relative
to their dimers, respectively (Figure 7, Table 2). Finally, and
Figure 6. Molecular docking models of NCN-swapped BS-RNase and RNase A. (A), left panel, ‘‘quasi-linear’’ [40] NCNTT model: the stabilizing
intermolecular H-bonds between the two central subunits are indicated with orange circles; right panel, the same structure rotated 90u around the x-
axis. (B) modeled structure of RNase A NCNTT [40,41] reported for comparison.
doi:10.1371/journal.pone.0046804.g006
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notably, the present data become additionally intriguing by
observing that VIT1 cells are substantially resistant to RNase A
native monomer or multimers, i.e. ND, CD, CNCTT, NCNTT,
whose structural features have been previously described [20],
and/or also to a mixture of larger RNase A oligomers (L.O.), as it
is shown in Figure S5.
Altogether, these results indicate a potential therapeutic role for
BS-RNase multimers, support the idea that the increase of
cytotoxicity induced by RNase multimerization is correlated to
the augmented enzymatic activity versus dsRNAs or dsRNA/
DNA hybrids, but not towards ssRNA [20,42], and suggest also
that BS-RNase oligomers, being meta-stable, are active on the
mentioned RNAs during the initial phases [59] of gene
transcription.
Concluding remarks
The results presented in this work elucidate several structural
features underlying BS-RNase self-association through double
domain swapping [19], providing, for the first time, experimental
evidence for C-terminus swapping to occur in this protein, and the
functional consequences related to it. Furthermore, the seminal
enzyme displays to multimerize to a higher extent than RNase A
does (see Table 1).
In addition, and finally, the present work confirms that 3D
domain swapping event, although not cleared in all its aspects,
such as its predictability, is a very intriguing phenomenon often
associated to the incoming or settling of important biological
actions. In this context, RNases continue to represent interesting
models [20,55,60–62] to study protein aggregation through
domain swapping, and suggest that, when not leading to
fibrillization, a controlled protein self-association [31,32,55] can
be advantageous in terms of acquired or increased potentially
therapeutic biological activities, as it is for BS-RNase.
Materials and Methods
Materials
The QuikChange Site-Directed Mutagenesis Kit and protocol
(Stratagene, La Jolla, CA, USA) were used to produce the BS-
RNase mutants, starting from the pET-22b (+) plasmid cDNA
coding for the N67D-BS-RNase variant. The N67D substitution
prevents the spontaneous deamidation of Asn-67 in the native
protein, which should consequently be isolated as a mixture of
Asn, Asp and isoAsp variants at position 67 [44]. The biological
activity and the structural features of the three derivatives are
almost identical to those of the native enzyme [45], thus we used
the N67D variant to avoid side-reactions, and referred to as wild-
type (wt).
As for the (N67D/)K113N-BS-RNase variant, henceforth
named BSK113N, the mutagenic primers were 59-
GCTTGTGGCGGTAACCCGTCCGTGCC-39, and 39-
GGCACGGACGGGTTACCGCCACAAGC-5, confirming the
mutations by DNA sequencing. The mutant was produced and
purified from E. coli as a monomer, with Cys-31 and 32 linked to
two glutathione molecules [15]. After selectively reducing the
mixed disulfides, they were either carboxyamidomethylated with
iodoacetamide [63] to obtain monomers for CD analysis, or
dialyzed against 0.1 M Tris/acetate pH 8.4 followed by SEC onto
a Sephadex G-75 column to obtain dimers [64]. The protein
solution was incubated at 37uC for at least 72 h to reach the
equilibrium between the two MxM and M=M isoforms [6]. The
same protocol was used to express and purify N67D-BS-RNase
(wt), while both recombinant dimeric BS-RNases were treated
with Aeromonas proteolytica aminopeptidase (Sigma) [65] to remove
Met-1 before cytotoxicity arrays.
RNase A (R5500, type XII A), used here as a standard, and poly
(A)Npoly (U), were purchased from Sigma; yeast RNA was
purchased from Boehringer.
Production of BS-RNase oligomers
To prepare BS-RNase oligomers we followed two different
procedures: in the ‘‘classic’’ aggregation protocol [11], 5 to
50 mg/ml protein samples dissolved in 40% HAc were lyophilized
and re-dissolved in 0.2 M, or 0.4 NaPi, pH 6.7 [20,46]. As for the
thermally-induced oligomerization procedure, some of the condi-
tions used elsewhere [35,53] were chosen in this work. Half mg
BS-RNase samples were dissolved at 150–200 mg/ml in various
aqueous media (See Results and Discussion and Figure 5) and
Table 2. Enzymatic and cytotoxic properties of BS-RNase oligomers.
Enzymatic Specific Activity, 236C [20] Cytotoxic Activity
Yeast RNA (Kunitz units/mg
enzyme)
poly (A) : poly (U) (units/mg
enzyme) IC50
a (mg/ml) IC50 Potentiation Factor
b
BS-RNase species WT K113N WT K113N WT K113N WT K113N
D 14.862.5 13.261.8 9.360.9 7.860.4 15569.4 .240 1 1
TT2/N 10.162.0 10.361.6 29.461.8 28.662.3 13.260.6 65.665.1 11.7 .3.7
TT1/C 12.362.3 11.761.8 36.161.2 33.161.5 17.261.0 64.965.9 9.0 .3.7
L.O.c 10.362.6 9.862.0 38.063.1 37.361.5 9.160.5 38.162.7 17.0 .6.3





aIC50 mean values (6 S.D.) from three independent experiments on VIT1 cells after 72 h.
bfolds vs the IC50 value of native BS-RNase dimer D.
cL.O.: mixture of BS-RNase hexamers, octamers, and larger oligomers.
doi:10.1371/journal.pone.0046804.t002
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heated to 45, 50, or 60uC up to 1 h. At the end of each treatment,
a 80–100 fold excess of 0.2 M NaPi, pH 6.7, pre-heated at the
incubation temperature [35], was added. Each mixture was
brought to 0–4uC, and chromatographed through SEC.
Chromatographic purification and quantification of the
BS-RNase oligomers
Purification and analyses of the RNase oligomers were
performed through SEC using a Sephadex G-100 column
(7061.5 cm), flow rate 0.4–0.5 ml/min, or with Superdex 75 or
200 10/300 GL columns (GE-Healthcare) attached to an A¨KTA
FPLC system (GE-Healthcare), flow rate 0.08–0.10 ml/min [20],
at room temperature. The purified oligomers were kept at 4uC
until use, or concentrated with Millipore Centricon Ultra-filters
(C.O. 10 kDa) just before use.
BS-RNase multimers were chromatographed also through a
Source 15S HR10/10 or Mono-S cation-exchange columns (GE-
Healthcare): elution was performed with a 0.09–0.20 M NaPi
gradient, pH 6.7 [20]; flow rate was between 0.4 and 1.2 ml/min.
Additional experiments were performed different buffers and/or
gradients: start from 0.10, 0.15, or 0.20 M NaPi, gradient to
0.40 M NaPi, pH 6.7; or, finally, 0.10 M NaPi, pH 6.7, with a
0.05 to 0.40 M NaCl gradient.
The concentration of BS-RNase and RNase A species was
spectrophotometrically measured at 278 nm with a e1%278 of 4.65
[66], and at 280 nm, e1%280 of 7.3 [67], respectively. Each RNase
oligomer amount was measured also as the percent area of its SEC
peak relative to the sum of the areas of all peaks eluted. The values
reported are means of five to eight measurements.
Cross-linking
Cross-linking with divinylsulfone (DVS) was performed follow-
ing the method of Ciglic et al. [48], with slight modifications: the
reaction was performed for 315 h at 20uC, not 30uC [48], to
minimize the possible tetramers’ dissociation. At the chosen times,
aliquots of 20 mg of the protein were withdrawn to quench the
reaction by adding b-mercaptoethanol, to a final concentration of
0.2 M. Each aliquot was kept at 4uC, until 8 mg of it were
subjected to SDS-PAGE.
1,5-difluoro-2,4-dinitrobenzene (DFDNB) was used by using the
protocol of Lin et al. [49], with some modifications in order to limit
a contemporary undesired oligomer’s dissociation. 0.2 mg/ml of
each oligomeric RNase species were dissolved in 0.1 M NaPi, and
brought to pH 8.0 with few microliters of Na2B4O7. Four
microliters of DFDNB, 0.37 mM in 2% (v/v) methanol solution,
were added every 8–10 min, over a 3 h period, to the RNase
species separately kept and stirred in the dark at 8uC, to a final
molar RNase/DFDNB ratio of about 1:2. The stirring was
protracted for additional 20 h, and samples were finally concen-
trated to 1 mg/ml to be analyzed through SDS-PAGE. The same
procedure was followed for BS-RNase native dimer, but in 50 mM
borate buffer, pH 8.5, at room temperature [49], but additionally
stirring in the dark for not more than 4 h to limit protein
precipitation.
Gel electrophoresis
SDS-PAGE (10, 12.5, or 15% polyacrylamide gel, Tris/glycine
buffer, pH 8.3) was performed at 20 mA, for 70–120 min,
depending on % of polyacrylamide, at room temperature.
Cathodic PAGE under non-denaturing conditions was per-
formed according to Goldenberg [47], with slight modifications,
using a pH 4.0 b-alanine/HAc buffer. 7.5, 10, or 12.5%
polyacrylamide gels were run at 20 mA for 60–100 min, at 4uC,
fixed with 12.5% trichloroacetic acid and stained with 0.1%
aqueous Coomassie brilliant blue.
Dynamic Light Scattering (DLS)
DLS measurements were performed following the procedures
described in [68], and the data processed, on a Zetasizer Nano-S
device from (Malvern Instruments) to measure the hydrodynamic
diameter of the BS-RNase species dissolved in NaPi 0.2 M,
pH 6.7. The temperature of the sample was controlled by a
thermostat to within 60.1uC. The solution was filtered with
‘‘Anotop’’ filters immediately before use and 12.5645-mm
disposable cells equipped with stopper were used.
Molecular modelling and docking
The structures of the C-swapped dimeric wt BS-RNase and
BSK113N were modelled starting from the NMR structure of the
monomeric BS-RNase derivative (mBS, PDB code 1QWQ [15]),
and from the RNase A C-dimer crystallographic structure (PDB
code 1F0V [38]), respectively. The mentioned atomic coordinates
were used as a template to predict the 3D structure of the variants,
Figure 7. Action of BS-RNase oligomers on the proliferation of
mesenchimal VIT1 cells. (A) wt, and (B) K113N BS-RNase. Cells were
cultured in RPMI 1640 medium supplemented with 2 mM glutamine,
10% FBS, and 50 mg/ml gentamicin sulphate. After addition of the BS-
RNase species, 10 to 240 mg/ml of BS-RNase (native) dimer, or of 10 to
80 mg/ml of BS TT1/C, TT2/N, or a mixture of larger oligomers (L.O.), cells
were incubated for 72 h at 37uC with 5% (v/v) CO2. At the end of the
treatments cells were stained with a Crystal Violet solution and the
survival was measured, and compared to the control lacking any RNase
species, as reported in Materials and Methods. Experiments were
performed in triplicate; the S.D. are comprised between 4.5 and 6.0% for
wt (A), and between 5.1 and 7.7% for K113N BS-RNase (B).
doi:10.1371/journal.pone.0046804.g007
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using the Modeller 9.9 program [69], and the score of variable
target function method [70] to evaluate the quality of the models.
BS-RNase tetrameric models were built by docking using
GRAMM-X (http://vakser.bioinformatics.ku.edu/resources/
gramm/grammx). The starting structures used for the docking
were two BS-RNase MxM dimers (PDB code 1BSR [57]). In each
of them, the same W and y dihedral angles of the RNase A C-
dimer crystallographic structure (PDB code 1F0V [38]) were
imposed to the C-terminal residues 110–124. To perform the
docking it was imposed that the interface of each dimer included
the 111–113 residues of the C-swapped chain(s). The quality of the
tetramers so obtained was checked with ANOLEA [71], and all
the structures were virtualized with PYMOL [72].
Biological assays
Enzymatic assays. The enzymatic activities of the BS-
RNase and RNase A species were measured at 23uC [20], using
a thermostatically controlled Beckman DU-650 spectrophotome-
ter. Assays with yeast RNA as a substrate were performed using
0.5 mg of each RNase (BS or A) species at 300 nm, according to
the method of Kunitz [73]. Assays with dsRNA poly(A)Npoly(U)
were performed, as described in [12], at 260 nm, with 5 mg of BS-
dimer, and 2 mg of each BS-tetramer (TT1 or TT2), and of larger
oligomers (L.O.). Concerning RNase A, the amounts used were:
monomer, 12 mg; dimers (ND or CD), 5 mg; tetramers (NCNTT or
CNCTT), 2 mg. The Abs260 and Abs300, respectively, were
recorded versus time, and the specific activity of the various
RNase species was calculated using the following equation: (DAbs/
time (min))/amount of enzyme (mg). All the enzymatic activity
values are means of three different assays 6 S.D.
In vitro cytotoxicity assays. The primary pancreatic
mesenchymal cell line VIT1 (Chemicon International, Milan,
Italy) was grown in RPMI 1640 supplemented with 2 mM
glutamine, 10% FBS, and 50 mg/ml gentamicin sulfate (BioWhit-
taker, Lonza, Bergamo, Italy) at 37uC with 5% CO2.
Cells were seeded in 96-well plates (2.56103 cells/well), then
treated 24 hours later with the various protein species, and further
incubated for 72 h. At the end of the treatment, cells were stained
with a Crystal Violet solution (Sigma, Milan, Italy). The dye was
solubilised in PBS containing 1% SDS and spectrophotometrically
measured (Abs595 nm) to determine cell growth. IC50 values were
obtained (mean 6 S.D.), and represent the concentration of the
various compounds when 50% growth inhibition is recorded.
Three independent experiments were performed for each assay
condition.
Supporting Information
Figure S1 Native PAGE of BS-RNase species eluted from
SEC visible in Figure 1B. 10% PAGEs under non denaturing
conditions [47] were performed with the BS-RNase species eluted
from SEC and concentrated to 0.6–0.7 mg/ml, in NaPi 0.1 M
pH 6.7. (A) Only the fractions corresponding to tetramers (5 and
6) and dimer (7 and 8) were analyzed, together with the mixture
(Mix) of the aggregates not separated through SEC (right lane). In
this lane, 5 mg of RNase A monomer, less cationic and with a
lower mobility than BS-RNase native dimer, were also added.
Run-time 80 min; (B) Also the BS-RNase oligomers larger than
tetramers are analyzed: electrophoresis was extended for 110 min,
and the dimer D almost escaped out from the gel (lanes 7 & 8), but
more than one tetrameric (TT, lanes 4, 5 & 6) and hexameric (H,
lanes 3 & 4) conformers are present. Finally, more than one
octamer and/or larger oligomers (L.O., lanes 2 & 3) are probably
present, while only a light smear is visible in lane 1. The ‘Mix’ does
not contain here RNase A.
(TIF)
Figure S2 Oligomerization pattern of wt BS-RNase after
cross-linking of the native dimer with DFDNB. (A) The
cross-linked protein was first purified with Superdex 75 column
(dotted line) obtaining four main fractions (1–4). Each fraction was
separately induced to oligomerize from 40% HAc solutions [11].
The result obtained with fraction 3 (continuous line) is reported
together with the pattern relative to an aliquot of BS-RNase that
was not cross-linked (dashed line). The pattern of the cross-linked
protein shows the presence of both tetramers, and also a badly
resolved portion of larger oligomers. Flow rate 0.08 to 0.10 ml/
min, injected volume 25 ml. (B) Further purification of DFDNB-
BS-fraction 3 through a cation-exchange column Source 15S HR
10/10: the two patterns obtained under the two conditions chosen
(100 and 150 mM NaPi, pH 6.7) to better fix the protein to, and
elute it from, the resin are shown in blue and red lines,
respectively. The linear gradient applied to rise NaPi concentra-
tion from 0.10 or 0.15 M up to 0.40 M was applied after 20 ml
(three column volumes) from the elution start. Gradient time-
course: blue curves, 75 min; red curves, 62.5 min; flow rate,
1.2 ml/min. Continuous lines, DFDNB-BS-RNase-fraction 3
(panel A); dashed lines, native dimeric BS-RNase. The DFDNB-
BS portion(s) preceding the dashed+dotted vertical lines (limit to
avoid contamination of un-reacted BS-RNase, see dashed line-
patterns of native BS-RNase) were collected, desalted, concen-
trated and induced to oligomerize through lyophilization from
40% HAc solutions [11]. (C) The resulting mixture was analyzed
through SEC, Superdex 75 column: continuous line, sample
purified through SEC+cation-exchange (panels A+B) before
inducing its oligomerization; dashed line, sample purified only
with SEC (same pattern of panel A, continuous line), reported for
comparison. Flow rate 0.08 to 0.10 ml/min, injected volume
25 ml.
(TIF)
Figure S3 10% acrylamide SDS-PAGE of BSK113N tetra-
mers after their cross-linking with DFDNB. The lane
corresponding to TT2 (considered totally N-swapped) shows a
slightly higher amount of cross-linked products than the
corresponding TT1.
(TIF)
Figure S4 Alternative bent NCNTT models for TT1/C.
The modeled structures (A,B) display an increasing central
bending with respect to the one shown in Figure 6A, and
represent energy minima as well as the latter, but their
hydrodynamic diameter is less in agreement with the one
experimentally measured for BS-TT1/C (Figure 1, Figure 5).
(TIF)
Figure S5 Action of RNase A oligomers on the prolifer-
ation of mesenchimal VIT1 cells. Cells were cultured in
RPMI 1640 medium supplemented with 2 mM glutamine, 10%
FBS, and 50 mg/ml gentamicin sulphate. After the RNase A
species addition, 40 to 240 mg/ml, cells were incubated for 72 h at
37uC with 5% (v/v) CO2. At the end of the treatments cells were
stained with a Crystal Violet solution and the survival was
measured and compared to the control without any RNase
species. RNase A species: M, monomer; DN, N-swapped dimer;
DC, C-swapped dimer; TTN, NCN-swapped tetramer; TTC,
CNC-swapped tetramer; L.O., mixture of RNase A pentamers,
hexamers, and larger oligomers.
(TIF)
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Discussion S1 Discussion concerning the results de-
rived from the patterns reported in Figure S2.
(DOC)
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